Epstein-Barr Virus Protein Crucial To Its Role In Blood Cancers

Date:

April 6, 2005

Source:

University Of Pennsylvania Medical Center

Summary:

Researchers at the University of Pennsylvania School of Medicine have identified a link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein known to be expressed in a number of EBV-associated cancers. Their findings demonstrate a new mechanism by which EBV transforms human B cells from the immune system into cancerous cells, which can lead to development of B-cell lymphomas.

Share:

Total shares:

FULL STORY

Philadelphia, PA – Researchers at the University of Pennsylvania School of Medicine have identified a link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein known to be expressed in a number of EBV-associated cancers. Their findings demonstrate a new mechanism by which EBV transforms human B cells from the immune system into cancerous cells, which can lead to development of B-cell lymphomas.

Erle S. Robertson, PhD, Associate Professor of Microbiology and Director of Tumor Virology, with Penn's Abramson Cancer Center and MD/PhD student Jason Knight, published their results in the early March issue of Molecular and Cellular Biology.

Using human cell cultures infected with the Epstein-Barr virus, the investigators found that a specific viral protein targets a molecule that normally regulates the cell-cycle progression, or duplication process, of resting B cells. In the presence of this viral protein – called EBNA3C (for EBV nuclear antigen) – the cell cycle of the usually quiescent human B cells gets a jump start, which ultimately initiates uncontrolled growth.

EBV, a member of the herpesvirus family and one of the most common human viruses, plays a role in cancers such as lymphoproliferative diseases in transplant or AIDS patients, Burkitt's lymphoma, Hodgkin's lymphoma, and nasopharyngeal carcinoma, and also causes the well-known disease, infectious mononucleosis. As many as 95 percent of adults 20 years and older have been infected with EBV, but show no symptoms.

"Viruses that are associated with cancers typically target the cell cycle to gain control," says Robertson. "However, this is the first time that laboratory research into how EBV drives the cancer process has directly identified a critical component of the cell cycle for control. Now we can develop targeted therapeutics to disrupt the function of this viral protein." The researchers surmise that the first use of future therapies from these studies will be in lymphoproliferative disease in transplant and immunocompromised patients because this is a clear case of EBV-driven B-cell lymphoma.

The use of peptides to block the interaction between this essential EBV protein and the specific pathway in human B cells is currently underway. Initial studies show that the growth of EBV-associated cancer cells can be inhibited in tissue-culture assays. The investigators are actively pursuing this line of investigation for developing potential therapies.

###

This research was funded by the National Institutes of Health and the Leukemia and Lymophoma Society of America. Nikhil Sharma, a student from Cherokee High School, New Jersey who volunteers at Penn, was also a co-investigator in this study.

University Of Pennsylvania Medical Center. "Epstein-Barr Virus Protein Crucial To Its Role In Blood Cancers." ScienceDaily. ScienceDaily, 6 April 2005. <www.sciencedaily.com/releases/2005/03/050329131312.htm>.

University Of Pennsylvania Medical Center. (2005, April 6). Epstein-Barr Virus Protein Crucial To Its Role In Blood Cancers. ScienceDaily. Retrieved August 2, 2015 from www.sciencedaily.com/releases/2005/03/050329131312.htm

University Of Pennsylvania Medical Center. "Epstein-Barr Virus Protein Crucial To Its Role In Blood Cancers." ScienceDaily. www.sciencedaily.com/releases/2005/03/050329131312.htm (accessed August 2, 2015).

July 31, 2015  School is just around the corner, which means backpacks and packed lunches await your children. One expert offers tips for parents to promote healthy dental habits while away from ... read more

July 29, 2015  By blocking the expression of a certain gene in patients, researchers have contributed to the demonstration of great decreases in the concentration of triglycerides in their ... read more

July 29, 2015  Viewing aquarium displays led to noticeable reductions in blood pressure and heart rate, a research team found in the first study of its kind. They also noted that higher numbers of fish helped to ... read more

June 11, 2015  About 90 percent of adults worldwide are infected with Epstein-Barr virus, or EBV. The virus infects B cells (the white blood cells that make antibodies) and can contribute to B-cell-derived cancers, ... read more

Dec. 19, 2013  Most people are carriers of the Epstein-Barr Virus, which can trigger infectious mononucleosis. Those who become infected as adults are more at risk of becoming ill from it. By contrast, children who ... read more

Nov. 2, 2011  Epstein-Barr virus infects nine out of ten people worldwide at some point during their lifetimes. Infections in early childhood often cause no disease symptoms, but people infected during adolescence ... read more